Alloy Therapeutics Expands Partnership with AbbVie to Advance Next-Generation Antibody Discovery Platform

Alloy Therapeutics announced a new agreement with AbbVie to advance a novel antibody discovery platform aimed at generating highly specific and effective therapeutic antibodies. The collaboration gives AbbVie access to Alloy’s advanced technologies to enhance its research and drug development capabilities. This partnership reflects Alloy’s broader strategy of expanding its platform ecosystem through collaborations with major biopharma companies to accelerate innovation in biologics.

Learn More